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Abstract
Background: Depression is one of the most prevalent psychiatric disorders that imposes a heavy economic, emotional and social
burden on patients, families and society.
Objectives: The present study aimed to compare the effectiveness of acceptance and commitment therapy (ACT) and cognitive
therapy (CT) in treating Iranian women patients with major depressive disorder (MDD).
Methods: Nineteen women outpatients meeting DSM-IV-TR criteria for MDD without any axis 2 disorders were randomly (goal-
oriented and convenience sampling) assigned to one of two treatment conditions, i.e. ACT and CT. The intervention in acceptance
and commitment therapy group that was conducted was based on the Zeattle manual for major depressive disorder. Twelve thera-
peutic sessions were administered in the consulting center of Tehran university twice a week. The control group received 12 sessions
of cognitive therapy based on Ferry manual twice a week in the consulting center of Tehran university, too. The Beck depression
inventory-II-second edition (BDI-II), acceptance and act questionnaire (AAQ-II) and dysfunctional attitude scale (DAS) were adminis-
tered for pre-treatment, post-treatment and follow-up. The data was analyzed by repeated measures analysis of variance (ANOVA).
Results: ANCOVA results showed that there were significant differences between ACT and CT in dysfunctional attitude. The ACT
group demonstrated significant improvement in acceptance in the pre-test and post-test stage. All the participants demonstrated
significant improvement in depression.
Conclusions: As ACT improved depression and acceptance of internal experiences, it is recommended for depression as an effective
psychotherapy.
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1. Background
Depression is one of the most prevalent psychiatric dis-
orders that imposes a heavy economic, emotional and so-
cial burden on patients, families and society (1). Approx-
imately 121 million people suffer from depression world-
wide (2). Currently, depression ranks fourth among the 10
leading causes of global disorders costs, and it is predicted
that it will be the second leading cause of financial bur-
den globally by 2020 (3). Studies have also showed that
prevalence of depression among Iranians is quite high (4-
6). Concerning the high prevalence and negative conse-
quences of depression, the effectiveness of different types
of drugs and psychological interventions on depression
has been investigated. During the past three decades,
about 200 studies have compared the effectiveness of psy-
chological interventions.
In controlled situations and other therapies (7), results
have demonstrated the effectiveness of psychological in-
terventions in the treatment of depression (7-9). One of the
most common psychological interventions is cognitive be-
havioral therapy (CBT). The effectiveness of CBT has been
confirmed in different studies (10). In some cases, CBT was
considered as an alternative treatment for depression (11,
12). The theoretical basis of CBT in depression arises from
the behavioral and cognitive theories of depression. In
Beck and Alford’s theory (13), which is the most important
and well-arranged cognitive theory of depression, nega-
tive thoughts may cause depression in people. According
to Beck, depression is characterized by individuals’ nega-
tive views of self, world, environment, and future which
form a cognitive triangle. It is hypothesized that if nega-
tive schemas become active, they would develop cognitive
biases with the inclination to process information nega-
tively, thus leading to low and reduced mood (14). In con-
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clusion, it can be mentioned that Back’s approach gives pri-
ority to negative beliefs and attitudes in reducing mood.
The cognitive approaches try to treat depressed patients
through changing the cognitive content of their thoughts.
Although studies have shown that cognitive behavior ther-
apy is the most effective psychological treatment for major
depression (11, 12), this approach does not address the ther-
apeutic needs of all patients. The outcome studies using
Beck’s depression inventory (BDI) have reported that only
40% - 58% of patients show improvement without any re-
lapse at the end of the treatment (15, 16).
A newer subcategory of CBT, sometimes referred to
as acceptance-based behavior therapies, has risen to em-
inence in recent years. Examples include mindfulness-
based cognitive therapy (17), mindfulness-based stress re-
duction (18), acceptance-based behavior therapy for gen-
eralized anxiety disorder (19), dialectical behavior therapy
(20) and acceptance and commitment therapy (21), among
others. Of these therapies, ACT has received the most atten-
tion on the subject of empirical study (22) and scientific ar-
gument (23, 24).
At the level of technology, there are some important
differences in how ACT and CT treat psychopathology (25).
CT makes use of cognitive disputation and other forms of
reappraisal (including behavioral experiments) designed
to correct systematic biases in information processing,
with the goal of reducing symptom intensity (26). The
goal of ACT is not symptom reduction per se, but rather
helping patients to accept difficult internal experiences
(thoughts, images, emotions, sensations) in the service of
engaging in values-consistent behavior change. ACT has
demonstrated preliminary effectiveness across a range of
problem behaviors, including mood (27) and anxiety (28)
disorders, among others. In ACT, depression is conceptual-
ized as a secondary emotion that arises from struggling to
avoid normal and adaptive emotional reactions to distress-
ing life events, for example, loss (29). Job loss is relevant to
those on sick leave or unemployed as job loss increases de-
pression (30). A meta-analysis (22) reported ACT to be su-
perior to active treatments, including standard CBT. How-
ever, Ost (31) has criticized the rigors of the trials on which
the meta-analysis relied, and a subsequent meta-analysis
(32) concluded that ACT was equally effective as established
treatments. The RCT upon which the study was based simi-
larly detected no differences in efficacy between ACT and
CT at post-treatment in the treatment of depression and
anxiety (33).
The core difference between ACT and other acceptance-
based interventions is the central proposition that diag-
nostically distinct clinical disorders may be established
and maintained through common processes that are
rooted in the capacity for language (34). These com-
mon processes include psychologically deleterious expe-
riential avoidance (34). EA has been defined as an unwill-
ingness to experience feelings, physiological sensations,
and thoughts, especially those that are negatively evalu-
ated (e.g., fear), as well as attempts to alter the form or
frequency of these events and the contexts that occasion
them (35). EA has been theorized to underlie a broad range
of topographically dissimilar disorders, and has been a
central feature of much ACT research, perhaps because the
acceptance and action questionnaire (36) provides a read-
ily available measure of the process. Ruiz (37) reported 20
studies have obtained 22 correlations between some ver-
sion of AAQ and standard measure of depressive symp-
toms.
Bohlmeijer et al. (38) examined the efficacy of an early
intervention based on ACT for depressive symptomatology.
Adults with mild to moderate depressive symptoma-
tology were randomly assigned to the ACT intervention (n
= 49) or to a waiting list (n = 44). The mean age of the par-
ticipants was 49 years. All the participants completed mea-
sures before and after the intervention, and three months
later at follow-up. The ACT intervention led to statistically
significant reduction in depressive symptomatology (Co-
hen’s d = 0.60) and significant reductions in anxiety and fa-
tigue after intervention the three-month follow-up. More-
over, mediational analysis showed that the improvement
of acceptance during the intervention mediated the ef-
fects of the intervention on depressive symptomatology at
follow-up.
In another study, Folke et al. (39) investigated the fea-
sibility of a brief ACT in a Swedish sample of unemployed
individuals on long-term sick leave due to depression. Par-
ticipants were randomized to a nonstandard zed control
condition (n = 16) or to the ACT condition (n = 18) consisting
of 1 individual and 5 group sessions. From pretreatment
to 18-month follow-up, the ACT participants improved sig-
nificantly on measures of depression, general health, and
quality of life compared to participants in the control con-
dition. The conditions did not differ regarding sick leave
and employment status at any point in time.
In a randomized controlled effectiveness trial of ACT
and CT for anxiety and depression, 101 heterogeneous out-
patients reporting moderate to severe levels of anxiety or
depression were randomly assigned to CT or to ACT (For-
man et al. (33). Whereas improvements in depression, anx-
iety, functioning difficulties, quality of life, life satisfaction,
and clinician-rated functioning were equivalent across the
two groups, the mechanisms of action appeared to differ.
Changes in observing and describing one’s experiences ap-
peared to mediate outcomes for the CT group, whereas
experiential avoidance, acting with awareness and accep-
tance mediated outcomes for the ACT group.
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As it seems that no study has yet been done to compare
the effectiveness of this therapeutic approach with other
approaches in major depressive disorder (MDD) patients
in Iran, the current study investigated the effectiveness of
ACT versus CT in the treatment of MDD, and we decided to
examine its efficacy in an Iranian sample.
2. Objectives
The present study aimed to compare the effectiveness
of acceptance and commitment therapy (ACT) and cogni-
tive therapy (CT) in treating Iranian women patients with
major depressive disorder (MDD).
3. Patients and Methods
This was a clinical trial study with two groups, i.e. two
experimental groups. The subjects were assigned to the
groups using simple randomization. All patients signed
informed consent. The population included patients with
moderate to severe MDD without psychotic features. Goal-
oriented and convenience sampling were used for select-
ing participants among patients who had been referred to
the counseling center of Tehran university in Tehran, Iran.
Subjects of the first experimental group received accep-
tance and commitment therapy. The second group under-
went cognitive therapy.
Pre-tests, post-tests and three-month follow-ups were
done on all the study subjects. Assessments and treat-
ments were administered in an outpatient setting by a
PhD student clinical psychology. The study design can be
shown as follows:
1, EG1 O1 X** O2; 2, EG2 O3 X* O4
EG1 and EG2 represent two experimental groups, re-
spectively. O1 and O3 represent pre-tests of the two groups,
and O2 and O4 denote post-tests of the groups. The X**
shows ACT, and X* indicates CT. The subjects were diag-
nosed by a psychiatrist and a clinical psychologist through
psychiatric as well as structured clinical interviews. The
mixed repeated measures analysis of variance (ANOVA)
was applied for data analysis using SPSS for Windows 19.0
(SPSS Inc, Chicago, IL, USA) by a statistician unfamiliar with
the study groups.
3.1. Population and Sampling
The population included patients with MDD. Goal-
Oriented and convenience sampling were used for select-
ing participants among patients who had been referred to
the university outpatient clinics in Tehran, Iran. Subjects
of the study comprised 19 people who had been referred to
the aforementioned center. According to the Cohen tabu-
lation, to determine the sample size with the level of sig-
nificance of 2.5% and the power of 80%, and according to
statistical tables, z0.8° = 0.8416 and z0.975° = 1.96, 10 patients
are needed in each group.
They had the following inclusive criteria:
1, having diagnosis criteria for MDD according to the re-
sults of structured clinical interview for DSM-IV, Axis I, clin-
ical version (SCID-I/CV) determined by a psychiatrist and a
clinical psychologist; 2, receiving no psychological thera-
pies during six months before participation in the study; 3,
age between 18 - 35 years; 4, signing the informed consent
for participating in the study.
The exclusive criteria were as follows:
1, having psychotic symptoms, drug abuse according
to the results of the diagnostic interview and the results of
the SCID-I/CV determined by the psychiatrist and psychol-
ogist and having serious suicidal thoughts, as these can
negatively affect compliance; 2, having complete criteria
of personality disorder at Axis II determined by the psychi-
atrist and clinical psychologist through the diagnostic in-
terview and results of the SCID-II test.
3.2. Instruments
3.2.1. Structured Clinical Interview for DSM-IV Axis I Disorders
SCID-I
Structured clinical interview for statistical manual of
mental disorders, 4th edition, (DSM-IV) Axis I disorders
SCID-I (structured clinical interview for DSM-IV), clinical
version (SCID-I/CV) is a comprehensive and standardized
instrument for the assessment of major mental disorders
in clinical and research settings (40). SCID-I is adminis-
tered in a single session and takes about 45 to 90 minutes.
Validity and reliability of this instrument have been con-
firmed in several studies (41). Zanarini et al. (42) have re-
ported inter-rater diagnostic reliability with Kappa higher
than 0.7 in most cases. The Persian version of this question-
naire has been provided by Sharifi et al. (43). Validity of the
instrument has been confirmed by clinical psychologists,
and its retest reliability was 0.95 for one week.
3.2.2. Structured Clinical Interview for DSMIV Axis II Disorders
SCID-II
Similar to SCID-I, SCID-II is a structured diagnostic in-
terview for personality disorder to assess 10 personality
disorders at DSMIV Axis II, depressive and aggressive dis-
orders, part of NOS (not otherwise specified), which were
suggested by First et al. (44).
An investigation has been conducted with 284 subjects
from four psychiatric centers and two non-psychiatric cen-
ters by two interviewers at two different times in order to
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determine the test- retest reliability in a two-week interval
and during two different times.
The Kappa coefficient was 0.24 for OCD, 0.74 for histri-
onic personality disorder and 0.53 for all psychiatric pa-
tients. The inter-rater agreement was low (Kappa = 0.38)
among non-psychiatric patients (44). The content valid-
ity of the Persian version has been confirmed by some psy-
chology professors, and its reliability was 0.87 through
test-retest with a one-week interval (45).
3.2.3. Beck Depression Inventory, Second Edition
(BDI-II), the Beck depression inventory, second edition,
is the revised Beck depression inventory (BDI), which was
designed to assess the severity of depression in adoles-
cents and adults (44). Compared to the first edition, the
second edition of the Beck inventory is more compatible
with DSM-IV. In fact, it covers all depression items based on
the cognitive theory. Cronbach’s alpha was 0.86 and inter-
nal consistency coefficient was 0.92 among Americans (46)
and 0.91 and 0.94 among Iranians, respectively (47).
3.2.4. Dysfunctional Attitude Scale (DAS)
Dysfunctional attitude scale (DAS) is a commonly used
self-report measurement of fundamental cognitive atti-
tudes of Beck’s theory for depressive symptoms. The scale
has 40 items in two parallel forms that are rated on a 7-
point Likert scale ranging from 1 (not true) to 7 (very true).
The DAS has demonstrated satisfactory reliability (α= 0.85)
and validity in previous studies. One study evaluated DAS
in Iranian subjects and confirmed its factor structure and
showed that the DAS test-retest reliability and internal con-
sistency for total score were 0.90 and 0.75, respectively, and
the correlation between DAS and BDI-II was 0.65 (48).
3.2.5. Acceptance and Action Questionnaire-II (AAQ-II)
The AAQ-II (Hayes et al., submitted for publication) is
a 10-item scale developed to assess the same construct as
the original AAQ (36). AAQ-II is a short general measure
of psychological acceptance or the readiness to experience
unwanted private experiences, such as bodily sensations,
emotions, thoughts and memories, in the pursuit of one’s
values and goals. It is sometimes referred to as a mea-
sure of psychological flexibility. Patients are asked to rate
each statement on a scale from 1 (never true) to 7 (always
true). Higher scores represent higher levels of general ac-
ceptance. The AAQ has been shown to have good validity
and adequate internal consistency (36). Zargar (49) admin-
istered AAQ-II in the Iranian population. She administered
this scale on 30 dormitory students of Tehran University of
Medical Sciences. In this sample, the AAQ-II demonstrated
adequate internal consistency (α = 0.86).
All stages of this project including sampling, review
literature, administration of two interventions and data
analysis took from July 2012 to September 2013. The inter-
vention in the ACT group was conducted based on the Zeat-
tle manual for major depressive disorder. The content of
ACT protocol included identifying experiential avoidances,
cognitive defusion, acceptance, and mindfulness exercise
and clarifying values.
The content of cognitive therapy based on the Ferry
manual as the control group included relaxation, identify-
ing automatic thoughts, downward arrow and providing
cognitive map. Twelve therapeutic sessions were adminis-
tered in the consulting center of Tehran university twice a
week.
4. Results
Subjects of the study included 19 patients (10 patients
in the ACT group, 9 patients in the CT group). All of the
participants were female and were under pharmacologi-
cal therapy. The mean and standard variation (SD) of the
participants’ age were calculated as 25.2 and 4.2, respec-
tively. There were no significant differences between the
two groups regarding age, education, and marital status.
Table 1 illustrates the mean and standard deviation (SD)
of the control and experimental groups on the depression,
dysfunctional thoughts, and acceptance of internal experi-
ences in pretest, post- test, and follow-up sessions. The re-
sults indicated that the mean and SD of the groups on all
scales were close to each other in the pretest.
Table 1. Mean and standard deviation of Beck Depression Inventory II Second Edi-
tion (BDI-II), Dysfunctional Attitude Scale (DAS) and Acceptance and Act Question-
naire (AAQ-II) in Pretest, Post-Test and Follow-Upa
Scale Pretest Post Test Follow-Up
BDI-II
ACT 33.3± (11.25) 28.2± (16.28) 20.7± (17.55)
CT 28.4± (7.74) 18.54± (7.65) 14.2± (7.82)
DAS
ACT 164.6± (25.26) 154.1± (29.33) 151.5± (25.11)
CT 150.22± (27.93) 128.77± (9.84) 128.55± (15.46)
AAQ-II
ACT 37.4± (6.88) 42.3± (10.42) 44.8± (10.88)
CT 39.6± (8.76) 40.5± (6.91) 38.8± (11.22)
aValues are expressed as mean± SD.
According to Table 2, as well as the results of the post-
hoc tests for paired comparisons with Bonferroni correc-
tion, there were no statistically significant differences in
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depression scores between the groups in the pretest phase.
In other words, this indicates the homogeneity of the
groups in terms of depression scores.
The result of mixed repeated measures of ANOVA
demonstrated a significant effect on phase (F (2, 34) = 14.54,
P = 0.00, η2 = 0.9). At post-test, however, no significant dif-
ferences were observed in terms of depression scores be-
tween the experimental (ACT) and control group (CT) (P >
0.05). Similar results were noted at the follow-up stage.
Across the pretest to follow-up stage, depression scores im-
proved significantly in the ACT group; while depression
enhanced across pre- to post-test and pretest to follow-up
stage in the CT group.
According to Table 2, as well as the results of the post-
hoc tests for paired comparisons with Bonferroni correc-
tion, there were no statistically significant differences in
dysfunctional attitude scores between the groups in the
pretest phase. In other words, this indicates the homo-
geneity of the groups in terms of dysfunctional attitude
scores.
The result of mixed repeated measures of ANOVA
demonstrated a significant effect on phase (F (2, 34) = 6.26,
P = 0.005, η2 = 0.86). At post-test, however, significant dif-
ferences were observed in terms of dysfunctional attitude
scores between the experimental (ACT) and control group
(CT) (P < 0.05). Similar results were noted at the follow-
up stage. Across the pre- to post-test and pretest to follow-
up stage, dysfunctional attitude scores improved signifi-
cantly in the CT group, while there were no statistically sig-
nificant differences in dysfunctional attitude scores in the
ACT group across the pre- to post-test and pretest to follow-
up stage.
According to Table 2, as well as the results of the
post-hoc tests for paired comparisons with Bonferroni cor-
rection, there were no statistically significant differences
in acceptance of internal experience scores between the
groups in the pretest phase. In other words, this indi-
cates the homogeneity of the groups in terms of accep-
tance scores.
The result of mixed repeated measures of ANOVA
demonstrated no significant effect on phase (F (2, 34) = 1.6,
P = 0.2, η2 = 0.0.8). At post-test, however, there were no sig-
nificant differences in terms of acceptance of internal ex-
perience scores between the experimental (ACT) and con-
trol group (CT) (P = 0.1). Similar results were noted at the
follow-up stage (P = 0.3). Across the pre- to post-test stage,
acceptance scores improved significantly in the ACT group
while there were no statistically significant differences in
acceptance of internal experiences scores across the pre- to
post-test and pretest to follow-up stage in the CT group.
5. Discussion
This study aimed to investigate and compare the effec-
tiveness of acceptance and commitment therapy and cog-
nitive therapies in treating patients with MDD. Results of
the study were in accordance with the preceding studies
(39) indicating that acceptance and commitment therapy
was effective in reducing the severity of depressive symp-
toms.
The ACT approach to thoughts in general and negative
thoughts in depression does not emphasize the content,
form, or frequency of thoughts as problematic. Instead,
how one relates to them (i.e., the function of thoughts) is
highlighted. The tendency to behave in accordance with
the content of thoughts is called cognitive fusion; it is
via defusion and other processes that clients learn to hold
thoughts more lightly and choose action based on values
instead of the content of thoughts. Defusion was found
to mediate outcomes in Zettle and Hayes’ (27) and Zettle
and Rains’ (50) trials for depression. In addition, results
of our study showed that cognitive therapy was effective
in decreasing the severity of depression. Cognitive thera-
pies improve depression through changing and modifying
dysfunctional beliefs and cognitive biases. The aim of ther-
apy is to identify and change dysfunctional thoughts and
beliefs. In CT, the therapist confronts the negative emo-
tions through reconstruction of client’s thinking process
in a way that logical thoughts replace dysfunctional ones
(26).
In line with Forman et al. (33), the results of this
study showed no statistically significant differences be-
tween these two approaches in improving symptoms of de-
pression. It can be concluded that the fundamental differ-
ences between CT and ACT are philosophical and theoreti-
cal rather than technological (24).
The defining feature of CT is the assumption that ther-
apeutic effects are mediated by changes in cognitions,
including thoughts, beliefs and schemas and the corre-
sponding emphasis on cognitive change efforts (33). In ad-
dition, the result of our study demonstrated that as we ex-
pected, CT decreased dysfunctional attitude significantly.
CT places emphasis on the content of thoughts as prob-
lematic, while ACT highlights the function of thoughts and
behavior in accordance with the content of thoughts via
defusion.
Therefore, the findings pointed to significant differ-
ences between the two approaches in the decrease of dys-
functional attitude, and the effect of ACT on DAS was not
significant. Zettle et al. (51) reanalyzed the data of the two
earliest clinical trials that compared 12 weeks of group CT
with group ACT. They concluded that DAS did not mediate
the outcomes and it could be viewed as a weak suppressor.
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Table 2. Repeated Measures ANOVA and Bonferroni Pairwise Comparisons for ACT Group Means: Pre-Test, Post-Test and Three-Months Follow-Up
Scale Pre-Test to Post-Test Pre-Test to Follow-Up Post-Test to Follow-Up
Mean Difference P Value Mean Difference P Value Mean Difference P Value
BDI-II
ACT 5.1 0.15 12.6 0.04 7.5 0.48
CT 9.8 0.02 14.2 0.007 4.3 0.29
DAS
ACT 10.5 0.7 13.1 0.3 2.6 1
CT 21.44 0.04 21.66 0.05 0.22 1
AAQ-II
ACT -4.9 0.029 -7.4 0.075 -2.5 1
CT -0.88 1 0.78 1 1.66 1
In line with Bohlmeijer et al. (38), another finding in
our study showed that acceptance of internal experiences
such as emotions and thoughts in the ACT group increased
significantly compared to CT. They suggest that an early in-
tervention based on ACT, aimed at increasing acceptance,
is effective in reducing depressive symptomatology.
Rector (52) says that the goal of ACT is not changing
cognitions or symptoms, as in CBT, but learning to become
mindful and accepting of cognitions and symptoms, and
pursuing valued behavior. Also, while there was a mean
increase in acceptance of internal experiences in cogni-
tive therapy, this difference did not reach statistical signif-
icance. As CT tries to modify and control thinking errors
by using cognitive strategies such as identification of auto-
matic negative thoughts and cognitive biases, acceptance
of negative thoughts has not increased significantly. On
the other hand, because CT is capable of improving dys-
functional attitude through exploration contradictory evi-
dences and acceptance of internal experiences, the results
of this study showed no statistically significant differences
between these two approaches in improving acceptance of
emotions and thinking.
Although there are indeed important differences along
each of these dimensions, there is also a great deal of over-
lap. Comparisons of the models typically highlight distinc-
tions, and common grounds can be obscured. Ultimately,
both CT and ACT aim to reduce human suffering and are
committed to a scientific epistemology (24).
One of the main limitations of this study was the fact
that the same therapist administrated both ACT and CT,
which may have biased the results. It is, therefore, rec-
ommended that in future studies, different therapists con-
duct the therapeutic interventions. Regarding small sam-
ple size of this study, using only women students of Tehran
university, we recommend that investigators conduct sim-
ilar studies with a larger sample size and clinical popula-
tion including both sexes to extend generalization.
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